Neurocrine buys Soleno for US$ 2.9 bn; Novo says Wegovy pill outperforms Lilly’s Foundayo in cross-trial comparison
In Phispers this week, Neurocrine Biosciences announced the
acquisition of rare-disease drugmaker Soleno Therapeutics for US$ ...
Impressions : 1511

